Teva Pharmaceutical Industries (NYSE:TEVA) Issues FY 2023 Earnings Guidance

Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) updated its FY 2023 earnings guidance on Wednesday. The company provided EPS guidance of $2.25-$2.55 for the period, compared to the consensus EPS estimate of $2.27. The company issued revenue guidance of $15.00 billion-$15.40 billion, compared to the consensus revenue estimate of $15.02 billion. Teva Pharmaceutical Industries […]

Related Keywords

Israel ,United States ,America , ,News Ratings For Teva Pharmaceutical Industries Daily ,Advisor Group ,Morgan Stanley ,Sequoia Financial Advisors ,Ethic Inc ,Teva Pharmaceutical Industries ,Teva Pharmaceutical Industries Price Performance ,Get Free Report ,Pharmaceutical Industries ,Point Capital Management ,Financial Advisors ,Quantbot Technologies ,Pharmaceutical Industries Limited ,North America ,Teva Pharmaceutical Industries Daily ,Nyse Teva ,Teva ,Medical ,Guidance ,Earnings ,Preannouncement ,